Literature DB >> 2293021

Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.

J A Affholter1, C L Hsieh, U Francke, R A Roth.   

Abstract

We have recently described the isolation of a cDNA encoding an enzyme thought to be involved in the degradation of insulin by insulin-responsive tissues. This enzyme, referred to as insulin-degrading enzyme (IDE), is a cytosolic proteinase of 110,000 mol wt which shares structural and functional homology with bacterial protease III. The enzyme may function in the termination of the insulin response. We report here the mapping of the human and mouse IDE genes to human chromosome 10 and mouse chromosome 19, respectively, and evidence for the existence of a single complex IDE gene. We also describe the stable transfection of Chinese hamster ovary cells with a plasmid containing the IDE cDNA under the transcriptional control of the SR alpha promoter. The recombinant protein synthesized by these cells is indistinguishable from the isolated human enzyme in both its size and immunoreactivity and degrades insulin with a specific activity similar to that of the purified proteinase. Overexpression of IDE using this system should allow for a functional test of the role of IDE in insulin action. In addition, expression of various site-directed mutants of IDE will aid in identifying the residues of IDE and protease III that are essential to the activity of this unique family of proteinases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293021     DOI: 10.1210/mend-4-8-1125

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  20 in total

1.  Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.

Authors:  V Chesneau; K Vekrellis; M R Rosner; D J Selkoe
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 3.  Mouse chromosome 19.

Authors:  J L Guénet; M Watson; M F Seldin
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 4.  Mouse chromosome 19.

Authors:  J L Guénet
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 5.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

6.  Hyperglycaemia and hyperinsulinaemia: is insulin-degrading enzyme the missing link?

Authors:  J Fawcett; W C Duckworth
Journal:  Diabetologia       Date:  2009-06-06       Impact factor: 10.122

7.  Yeast Ste23p shares functional similarities with mammalian insulin-degrading enzymes.

Authors:  Benjamin J Alper; Jarrad W Rowse; Walter K Schmidt
Journal:  Yeast       Date:  2009-11       Impact factor: 3.239

8.  Cell-permeable, small-molecule activators of the insulin-degrading enzyme.

Authors:  Sayali S Kukday; Surya P Manandhar; Marissa C Ludley; Mary E Burriss; Benjamin J Alper; Walter K Schmidt
Journal:  J Biomol Screen       Date:  2012-06-26

9.  Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells.

Authors:  F Authier; P H Cameron; V Taupin
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

Review 10.  General anesthetics and β-amyloid protein.

Authors:  Zhongcong Xie; Zhipeng Xu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-14       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.